Congratulations to Dr. Jose Abisambra and collaborators on their latest publication in The Journal of Neuroscience.
Their newly published study explores how a specific genetic pathway involving PERK and DLX1 contributes to tau toxicity – offering important new insights into neurodegenerative diseases such as progressive supranuclear palsy.
This work highlights a novel mechanism driving tau-related pathology and helps advance our understanding of brain disorders linked to protein dysfunction and neurodegeneration.
“Progressive Supranuclear Palsy PERK Haplotype B Selectively Translates DLX1 Promoting Tau Toxicity“
We are proud to celebrate this impactful research and its contribution to advancing brain health and potential therapeutic targets!